1. Home
  2. NBTB vs TVTX Comparison

NBTB vs TVTX Comparison

Compare NBTB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTB
  • TVTX
  • Stock Information
  • Founded
  • NBTB 1856
  • TVTX 2008
  • Country
  • NBTB United States
  • TVTX United States
  • Employees
  • NBTB N/A
  • TVTX N/A
  • Industry
  • NBTB Major Banks
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NBTB Finance
  • TVTX Health Care
  • Exchange
  • NBTB Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • NBTB 2.0B
  • TVTX 1.7B
  • IPO Year
  • NBTB N/A
  • TVTX N/A
  • Fundamental
  • Price
  • NBTB $41.85
  • TVTX $15.02
  • Analyst Decision
  • NBTB Buy
  • TVTX Strong Buy
  • Analyst Count
  • NBTB 3
  • TVTX 14
  • Target Price
  • NBTB $52.33
  • TVTX $33.31
  • AVG Volume (30 Days)
  • NBTB 321.4K
  • TVTX 1.9M
  • Earning Date
  • NBTB 07-21-2025
  • TVTX 05-01-2025
  • Dividend Yield
  • NBTB 3.25%
  • TVTX N/A
  • EPS Growth
  • NBTB 17.05
  • TVTX N/A
  • EPS
  • NBTB 3.03
  • TVTX N/A
  • Revenue
  • NBTB $569,473,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • NBTB $26.51
  • TVTX $74.41
  • Revenue Next Year
  • NBTB $12.04
  • TVTX $48.90
  • P/E Ratio
  • NBTB $13.81
  • TVTX N/A
  • Revenue Growth
  • NBTB 13.26
  • TVTX 75.65
  • 52 Week Low
  • NBTB $34.47
  • TVTX $6.79
  • 52 Week High
  • NBTB $52.44
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • NBTB 43.88
  • TVTX 35.45
  • Support Level
  • NBTB $40.91
  • TVTX $16.37
  • Resistance Level
  • NBTB $42.74
  • TVTX $15.48
  • Average True Range (ATR)
  • NBTB 0.87
  • TVTX 1.00
  • MACD
  • NBTB -0.25
  • TVTX -0.51
  • Stochastic Oscillator
  • NBTB 20.22
  • TVTX 3.83

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: